You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 68 No. 3, September 1962 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Further Ocular Effects of Endotoxin

R. Z. LEVENE, M.D.; R. LONG, M.D.; A. LATESSA, Ph.D.

Arch Ophthalmol. 1962;68(3):360-368.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Endotoxin designates the relatively homogenous group of toxic substances which exist as polysaccharide protein lipid complexes in Gram-negative microorganisms. Two important features of these substances are their biologic potency and their ubiquity as contaminants. The active agent in fever or nonspecific protein therapy is endotoxin.

The potent biologic effects1 of these substances can be divided into nonspecific toxic actions of all endotoxins and specific immunologic effects of each strain. The toxic effects, typically biphasic, include fever production, profound vasomoter disturbances, alterations in the white cell and platelet counts, metabolic alterations, tumor necrosis, and the Shwartzman reaction. With repeated doses there is a rapid appearance of a state of nonspecific resistance or tolerance against further toxic effects.

In the normal rabbit eye a single parenteral administration of endotoxin produces an inflammation with a biphasic alteration in pressure.2,3 Tolerance to the ocular inflammation can be quickly developed by repeated administration. . . . [Full Text PDF of this Article]


Author Affiliations

New York

Department of Ophthalmology, New York University-Bellevue Medical Center.


Footnotes

Submitted for publication March 1, 1962.

These Investigations were supported by Research Grants-in-Aid from the Alfred P. Sloan Foundation, New York, and from the National Institute of Neurological Diseases and Blindness, United States Public Health Service (B-1951).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1962 American Medical Association. All Rights Reserved.